|
US4837151A
(en)
*
|
1980-05-19 |
1989-06-06 |
The Board Of Trustees Of The Leland Stanford Junior University, Stanford University |
Live vaccines comprising two mutations and foreign antigen
|
|
US5643771A
(en)
*
|
1980-05-19 |
1997-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-reverting live bacterial vaccines
|
|
ATE143414T1
(de)
|
1985-01-14 |
1996-10-15 |
Chiron Corp |
Hauptprotein der aussenmembran von chlamydia
|
|
US6030799A
(en)
|
1985-01-14 |
2000-02-29 |
Washington Research Foundation |
Immunoassays for detecting chlamydial antigens or antibodies thereto using recombinant or synthetic major outer membrane protein polypeptides as substitute antigens
|
|
IL86583A0
(en)
*
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5869608A
(en)
*
|
1989-03-17 |
1999-02-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
|
|
ES2090129T3
(es)
*
|
1989-03-31 |
1996-10-16 |
Univ Washington |
Vacunas que contienen microorganismos tipo phop avirulentos.
|
|
GB8912330D0
(en)
*
|
1989-05-30 |
1989-07-12 |
Wellcome Found |
Live vaccines
|
|
TW201794B
(https=)
*
|
1991-05-03 |
1993-03-11 |
American Cyanamid Co |
|
|
US5840297A
(en)
*
|
1993-03-19 |
1998-11-24 |
Johns Hopkins University |
Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process
|
|
CA2175081A1
(en)
*
|
1993-11-03 |
1995-05-11 |
James Evan Sandbulte |
Vaccine and method for treatment of chlamydial infections
|
|
US5629167A
(en)
*
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
|
US5877159A
(en)
*
|
1995-05-03 |
1999-03-02 |
University Of Maryland At Baltimore |
Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
|
|
US6682729B1
(en)
*
|
1995-05-03 |
2004-01-27 |
University Of Maryland, Baltimore |
Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
|
|
GB9516293D0
(en)
*
|
1995-08-09 |
1995-10-11 |
Immunova Ltee |
Novel peptides and their use as vaccines
|
|
US6001372A
(en)
*
|
1995-08-25 |
1999-12-14 |
Wisconsin Alumni Research Foundation |
Antigenic peptides of Chlamydia trachomatis
|
|
WO1997044446A1
(en)
*
|
1996-05-24 |
1997-11-27 |
University Of Maryland At Baltimore |
Dna vaccines for eliciting a mucosal immune response
|
|
US6180398B1
(en)
*
|
1996-07-12 |
2001-01-30 |
Virogeneitics Corporation |
Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
|
|
US6344202B1
(en)
*
|
1996-07-12 |
2002-02-05 |
University Of Manitoba |
DNA immunization against chlaymdia infection
|
|
US6235290B1
(en)
*
|
1997-07-11 |
2001-05-22 |
University Of Manitoba |
DNA immunization against chlaymdia infection
|
|
US6696421B2
(en)
*
|
1996-07-12 |
2004-02-24 |
University Of Manitoba |
DNA immunization against chlamydia infection
|
|
ATE312920T1
(de)
*
|
1996-07-12 |
2005-12-15 |
|
Dna immunisierung gegen chlamydia infektion
|
|
US6464979B1
(en)
*
|
1996-09-12 |
2002-10-15 |
Aventis Pasteur Limited |
Chlamydial vaccines and methods of preparation thereof
|
|
US6017735A
(en)
*
|
1997-01-23 |
2000-01-25 |
Marie Curie Cancer Care |
Materials and methods for intracellular transport and their uses
|
|
DK0977874T3
(da)
*
|
1997-04-18 |
2006-03-20 |
Biotechnolog Forschung Gmbh |
Svækket salmonella-stamme anvendt som bæremedium til oral immunisering
|
|
US5935816A
(en)
*
|
1997-07-23 |
1999-08-10 |
Smithkline Beecham Corporation |
Chlamydia trachomatis lysS polynucleotides
|
|
WO1999010005A1
(en)
*
|
1997-08-28 |
1999-03-04 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Vaccines for chlamydia psittaci infections
|
|
US7459524B1
(en)
*
|
1997-10-02 |
2008-12-02 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia protein, sequence and uses thereof
|
|
US6024961A
(en)
*
|
1997-11-14 |
2000-02-15 |
Washington University |
Recombinant avirulent immunogenic S typhi having rpos positive phenotype
|
|
DE69841894D1
(de)
*
|
1997-11-21 |
2010-10-21 |
Merck Serono Biodevelopment Sa |
Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
|
|
US7041490B1
(en)
*
|
1997-11-28 |
2006-05-09 |
Serono Genetics Institute, S.A. |
Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
|
|
US20020064517A1
(en)
*
|
1998-04-30 |
2002-05-30 |
Stewart A. Cederholm-Williams |
Fibrin sealant as a transfection/transformation vehicle for gene therapy
|
|
US6190669B1
(en)
*
|
1998-05-13 |
2001-02-20 |
University Of Maryland, Baltimore |
Attenuated mutants of salmonella which constitutively express the Vi antigen
|
|
WO2000006743A2
(en)
*
|
1998-07-27 |
2000-02-10 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
US6660275B2
(en)
*
|
1998-07-27 |
2003-12-09 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20030147924A1
(en)
*
|
1998-07-27 |
2003-08-07 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
US6693087B1
(en)
*
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
|
US6686339B1
(en)
*
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
|
WO2000011181A1
(en)
*
|
1998-08-20 |
2000-03-02 |
Connaught Laboratories Limited |
NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
|
|
US6403101B1
(en)
*
|
1998-10-28 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US6649370B1
(en)
*
|
1998-10-28 |
2003-11-18 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US6872814B2
(en)
*
|
1998-10-29 |
2005-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US6607730B1
(en)
*
|
1998-11-02 |
2003-08-19 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US6822071B1
(en)
*
|
1998-11-12 |
2004-11-23 |
The Regents Of The University Of California |
Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
|
|
CA2353107A1
(en)
*
|
1998-12-01 |
2000-06-08 |
Andrew D. Murdin |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
EP1169465B1
(en)
*
|
1998-12-04 |
2006-03-01 |
University Of Manitoba |
Two-step immunization procedure against chlamydia infection
|
|
US6448234B1
(en)
*
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
CA2354431A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
US7297341B1
(en)
*
|
1998-12-23 |
2007-11-20 |
Sanofi Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
JP2002541766A
(ja)
*
|
1998-12-28 |
2002-12-10 |
アベンティス、パストゥール、リミテッド |
クラミジア抗原および対応するｄｎａ断片ならびにその使用
|
|
US6808713B1
(en)
*
|
1998-12-28 |
2004-10-26 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
MXPA01009256A
(es)
*
|
1999-03-12 |
2003-07-14 |
Aventis Pasteur |
Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
|
|
DE60036698T2
(de)
*
|
1999-05-03 |
2008-07-24 |
Sanofi Pasteur Ltd., Toronto |
Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
|
|
US6191259B1
(en)
*
|
1999-05-19 |
2001-02-20 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US6811783B1
(en)
*
|
1999-09-07 |
2004-11-02 |
Aventis Pasteur Limited |
Immunogenic compositions for protection against chlamydial infection
|
|
AUPQ275799A0
(en)
*
|
1999-09-10 |
1999-10-07 |
Luminis Pty Limited |
Recombinant bacterium expressing an oligosaccharide receptor mimic
|
|
NZ517952A
(en)
*
|
1999-09-20 |
2004-01-30 |
Aventis Pasteur |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US6632663B1
(en)
*
|
1999-09-22 |
2003-10-14 |
Aventis Pasteur Limited |
DNA immunization against chlamydia infection
|
|
AU1375501A
(en)
*
|
1999-11-12 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
WO2001046226A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
AU2138501A
(en)
*
|
1999-12-22 |
2001-07-03 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
EP1240331B1
(en)
*
|
1999-12-22 |
2010-04-07 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
US20020082402A1
(en)
*
|
2000-04-04 |
2002-06-27 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20020094965A1
(en)
*
|
2000-04-04 |
2002-07-18 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20020132994A1
(en)
*
|
2000-04-04 |
2002-09-19 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20030100706A1
(en)
*
|
2000-04-04 |
2003-05-29 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20020071831A1
(en)
*
|
2000-04-04 |
2002-06-13 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
|
US20040254130A1
(en)
*
|
2000-05-08 |
2004-12-16 |
Murdin Andrew D |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
JP3653219B2
(ja)
*
|
2000-10-30 |
2005-05-25 |
シャープ株式会社 |
印刷装置およびそれを用いた通信装置または情報処理装置
|
|
CA2587493A1
(en)
*
|
2004-11-30 |
2006-06-08 |
Aeras Global Tb Vaccine Foundation |
Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
|